Andrew Stone
Andrew Stone
Latest posts from :
The digital therapeutics reimbursement process is maturing but complexity and...
Leveraging the full capabilities of digital will enable pharma to transform the...
Pharma knows the value of digital, yet it admits only a fraction of launches...
Gathering and acting on insights from digital patient engagement data is...
As big pharma ponders the right sizing of its post-pandemic field forces, can...
Post pandemic, pharma and regulators are both working to accelerate the...
Digital-first engagement is challenging pharma to deliver content on HCPs’...
Faster, better trials, enhanced pharmacoepidemiology and more ambitious...
The FDA is developing guidelines that will help pharma accelerate its adoption...
Spending on digital promotional and educational activity will continue to rise...